Clinical Trial Research Development

The NHMRC has a highly skilled team to support the development of new clinical trials and research activities.  Led by Kate Wilson, CTC’s Research Development Manager, the team of Research Development Leads work with oncology, COVID-19, and other therapeutic areas to develop new research to be conducted in collaboration with the CTC. 

The Research Development Leads work closely with Clinical Fellows, Clinical Leads, and Statisticians allocated by the CTC for activities with oncology collaborative groups co-located at the CTC.  Working as a team per collaborative group, these staff work with external academic partners to develop early concepts presented at group meetings into a final study design, assess feasibility and equipoise, develop study budgets, obtain funding and drug supply, prepare and submit government and philanthropic grants and manage the legal agreement processes.

With extensive experience in clinical trial development and conduct the research leads will provide study design recommendations and identify areas for special consideration during the concept and protocol development stage.

As part of the business development and research development role Kate meets with new researchers and research groups from a range of therapeutic areas to explore potential academic collaborations and new business development with researchers at the CTC.

To support this new business development, she leads a generalist research development team supporting the exploration and development of new academic collaboration for research in other therapeutic areas such as COVID-19, respiratory medicine, device trials, surgery, digital health and gene therapy.   

Kate also works with the Faculty of Medicine and Health Business Development team to assess new opportunities for the CTC.